Hansen TF - Search Results

1

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer.

Hansen TF, Sørensen FB, Lindebjerg J, Jakobsen A. Hansen TF, et al. BMC Cancer. 2012 Mar 8;12:83. doi: 10.1186/1471-2407-12-83. BMC Cancer. 2012. PMID: 22397399 Free PMC article.

2

Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer.

Hansen TF, Sørensen FB, Spindler KL, Olsen DA, Andersen RF, Lindebjerg J, Brandslund I, Jakobsen A. Hansen TF, et al. Virchows Arch. 2010 Mar;456(3):251-60. doi: 10.1007/s00428-009-0878-8. Epub 2010 Feb 9. Virchows Arch. 2010. PMID: 20143086

3

Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer.

Hansen TF, Jakobsen A. Hansen TF, et al. Pharmacogenomics. 2011 Dec;12(12):1681-93. doi: 10.2217/pgs.11.118. Pharmacogenomics. 2011. PMID: 22118052 Review.

4

The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer: results from the Nordic ACT trial.

Hansen TF, Christensen Rd, Andersen RF, Garm Spindler KL, Johnsson A, Jakobsen A. Hansen TF, et al. Int J Colorectal Dis. 2012 Jun;27(6):715-20. doi: 10.1007/s00384-011-1382-6. Epub 2011 Dec 6. Int J Colorectal Dis. 2012. PMID: 22139032 Clinical Trial.

5

Elevated microRNA-126 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in colorectal cancer.

Hansen TF, Andersen CL, Nielsen BS, Spindler KL, Sørensen FB, Lindebjerg J, Brandslund I, Jakobsen A. Hansen TF, et al. Oncol Lett. 2011 Nov;2(6):1101-1106. doi: 10.3892/ol.2011.372. Epub 2011 Aug 4. Oncol Lett. 2011. PMID: 22848274 Free PMC article.

6

Visualising and quantifying angiogenesis in metastatic colorectal cancer : A comparison of methods and their predictive value for chemotherapy response.

Hansen TF, Nielsen BS, Jakobsen A, Sørensen FB. Hansen TF, et al. Cell Oncol (Dordr). 2013 Jul;36(4):341-50. doi: 10.1007/s13402-013-0139-3. Epub 2013 Jul 10. Cell Oncol (Dordr). 2013. PMID: 23838926

7

Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers.

Zedan AH, Hansen TF, Fex Svenningsen A, Vilholm OJ. Zedan AH, et al. Among authors: hansen tf. Clin Colorectal Cancer. 2014 Jun;13(2):73-80. doi: 10.1016/j.clcc.2013.11.004. Epub 2013 Nov 13. Clin Colorectal Cancer. 2014. PMID: 24365057 Review.

8

Epidermal growth factor-like domain 7 predicts response to first-line chemotherapy and bevacizumab in patients with metastatic colorectal cancer.

Hansen TF, Nielsen BS, Sørensen FB, Johnsson A, Jakobsen A. Hansen TF, et al. Mol Cancer Ther. 2014 Sep;13(9):2238-45. doi: 10.1158/1535-7163.MCT-14-0131. Epub 2014 Aug 19. Mol Cancer Ther. 2014. PMID: 25140000 Clinical Trial.

9

The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort.

Hansen TF, Kjær-Frifeldt S, Morgenthaler S, Blondal T, Lindebjerg J, Jakobsen A, Sørensen FB. Hansen TF, et al. J Transl Med. 2014 Sep 10;12:254. doi: 10.1186/s12967-014-0254-6. J Transl Med. 2014. PMID: 25199818 Free PMC article.

10

Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study.

Hansen TF, Nielsen BS, Jakobsen A, Sørensen FB. Hansen TF, et al. J Transl Med. 2015 Jan 16;13:10. doi: 10.1186/s12967-014-0359-y. J Transl Med. 2015. PMID: 25592646 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page